Molecular and cellular paradigms of multidrug resistance in cancer
Abstract Background The acquisition of resistance to chemotherapy is a major hurdle in the successful application of cancer therapy. Several anticancer approaches, including chemotherapies, radiotherapy, surgery and targeted therapies are being employed for the treatment of cancer. However, cancer c...
Main Authors: | Foram U. Vaidya, Abu SufiyanChhipa, Vinita Mishra, Vishal Kumar Gupta, Shiv Govind Rawat, Ajay Kumar, Chandramani Pathak |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-12-01
|
Series: | Cancer Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/cnr2.1291 |
Similar Items
-
Ribosome-Induced Cellular Multipotency, an Emerging Avenue in Cell Fate Reversal
by: Arif Istiaq, et al.
Published: (2021-09-01) -
Cellular senescence in cancer: from mechanisms to detection
by: Hui‐Ling Ou, et al.
Published: (2021-10-01) -
Malignant clonal evolution drives multiple myeloma cellular ecological diversity and microenvironment reprogramming
by: Yuanzheng Liang, et al.
Published: (2022-09-01) -
Targeting cancer-specific metabolic pathways for developing novel cancer therapeutics
by: Soumik Pal, et al.
Published: (2022-12-01) -
Implications of Cellular Aging in Cardiac Reprogramming
by: Fabiana Passaro, et al.
Published: (2018-04-01)